Understanding the Scope of ER+ Breast Cancer – Targeted Oncology

Sara Hurvitz, MD: Hello, Im Dr Sara Hurvitz, professor of medicine at the University of California Los Angeles, Johnson Comprehensive Cancer Center. Im going to be discussing today the AMEERA-5 clinical trial which is a randomized double-blind phase 3 clinical trial evaluating amcenestrant with palbociclib vs letrozole plus palbociclib for previously untreated hormone receptor-positive HER2-negative [human epidermal growth factor receptor 2] advanced breast cancer.

When you look at the scope of breast cancer and the different subtypes of breast cancer, it is notable that hormone receptor-positive breast cancer comprises the largest proportion of all cancers diagnosed. Hormone receptor-positive breast cancer represents about two-thirds to three-fourths of all breast cancers diagnosed. In terms of stage of disease, most patients in the Western world [receive a diagnosis at] stage I, II, or III breast cancer, only about 10% of patients at their initial diagnosis are diagnosed with advanced disease, meaning incurable stage IV metastatic breast cancer.

However, approximately 90% of patients who are diagnosed with early-stage disease, they are at risk for the rest of their life of being diagnosed with metastatic breast cancer or stage IV breast cancer. The risk of developing advanced stage disease goes up by the stage at which a patient is diagnosed. If a patient [received a diagnosis of] stage I breast cancer, she has a lower risk of developing advanced disease than somebody who is diagnosed, for example, with stage III breast cancer.

The prognosis of breast cancer, just focusing on stage IV breast cancer, is evolving over time as we have the availability of new agents come up. We do know, from some recent studies that are registry clinical trials and follow how long patients are living who are diagnosed with advanced disease, that the median overall survival is roughly on the order of 40 months or so for hormone receptor-positive breast cancer, HER2-negative advanced breast cancer. These data come from a French registry trial called ESME-MBC in which all women diagnosed starting around 2008 with metastatic breast cancer with subtype known were followed and assessed for median overall. Although we now have cyclin-dependent kinase 4/6 inhibitors available for the treatment of this disease, the median overall survival over this time course has not increased. Its possible that in the future we will see the median overall survival improve as more time has passed and the data mature.

Transcript edited for clarity.

See the original post here:

Understanding the Scope of ER+ Breast Cancer - Targeted Oncology

Best Supplements to Take Before Bed, According to Dietitians – Eat This, Not That

We all could use more/better/deeper sleep these days. And less stress? Sign us up. Enhanced muscle gains? Ditto. As you wind down for the day, you may want to consider these health-supportive and sleep-promoting supplements, say dietitians.

From melatonin to Ashwagandha, read on for the best research-backed supplements to take before bed. It goes without saying, but, before adding a new supplement to your routine, always consult with a trusted healthcare professional. Read on, and for more on how to eat healthy, don't miss 7 Healthiest Foods to Eat Right Now.

Let's get the most commonly recommended natural sleep supplement out of the way first. There's a good reason it's such a frequently advised remedy for sleep issues: "The body produces melatonin naturally, with levels dipping in the morning and rising in the evening to promote the body's sleep-wake cycles," says Kylie Ivanir, MS, RD, who runs a private practice called Within Nutrition. "Given melatonin's role in regulating the circadian rhythm and signaling the body it is time to sleep, supplements of this hormone can help facilitate the transition to sleep and promote consistent rest. This may be the case for individuals managing jet lag, insomnia, or wanting to improve sleep efficacy," she continues, pointing to this scientific overview.

READ MORE: Best Supplements for Sleep, According to Experts

Here's another heavy hitter in the world of sleep, which may also help with issues like anxiety.

"Magnesium comes in various formulations that can be beneficial in different ways. Magnesium citrate differs from the other chelated forms, such as magnesium bisglycinate and magnesium threonate, which are readily absorbed and work intracellularly," explains Ivanir. "Magnesium bisglycinate, in particular, can help with relaxation, sleep, and anxiety reduction. Therefore, it can be beneficial to take this form of magnesium at night before bedtime," she says, citing this study. You can also get magnesium from a variety of food sources like bananas, dark leafy greens, nuts, avocados, and beans.

Echoing Ivanir, Roxie M. Calloway, MS, RD says "[magnesium] is a natural relaxant and helps with sleep quality. Magnesium can also help relieve stress, as it can inhibit cortisol production and potentially lower blood pressure. She adds that men should have around 300 mg and women around 200 mg per day, though some people may opt to take more. "Magnesium has a lot of other health benefits as well. Magnesium is an essential mineral that plays a role in more than 300 different enzyme systems in the body. It helps the body use calcium and oxygen properly, and it helps build healthy bones and teeth," she further notes.

RELATED: Sign up for our newsletter to get daily recipes and food news in your inbox!

"Passionflower has been used in alternative medicine for insomnia; yet, recent research has shown that passionflower may in fact impact your sleep quantity and quality. Sleep quantity refers to the total time you've spent sleeping, and sleep quality refers to how well you've slept," says Kim Rose, RDN, CDCES, CNSC, LD. "In order to achieve a good night's rest, the perfect balance of sleep quantity and quality must be met. A 2017 animal study showed that passionflower decreased wakefulness and showed a significant increase in the total time spent sleeping. As it related to sleep quality, one human study showed that passionflower tea was helpful. Though these studies are small, and more human research is needed before definitive claims can be made, passionflower may hold promising results for capping off your night," she elaborates.

This supplement may be a boon if you're looking for better sleep. "L-theanine is an amino acid mostly found in the green tea plant. A small 2016 study showed that L-theanine may have anti-stress benefits," explains Rose. "This is important because stress may also impact our sleep. Another study conducted in China showed that negative types of stress may promote sleep disturbance and disrupt overall sleep quality. For as much stress as modern-day society gives, L-theanine seems to be a smart choice."

Wrapping up for the night? If you're all about gym life, it might be a good idea to take a protein supplement before you hit the hay. "For active individuals, it can be beneficial to take a slowly digested protein supplement before bed. When utilized over a period of time in conjunction with strength training, pre-sleep protein can help increase muscle mass and strength, promote recovery, and improve performance," says Ivanir, referencing this research. "This may be due in part to the overnight spike in growth hormone, which helps synthesize muscle mass."

Calloway zooms in on casein protein (from eggs) as the best type: "It's a good idea to consume casein protein before bedtime to promote muscle growth due to its slow digestion. Casein, unlike whey, is a very thick protein that breaks down slowly in the stomach and helps give your muscles nutrients (while promoting growth hormone secretion) while you're asleep," says Calloway. "It's a complete protein with all essential amino acids and has been shown to increase lean muscle mass. When this protein is consumed just before going to bed, it helps promote muscle protein synthesis while allowing your muscles to recover from workouts overnight."

It may very well be time to befriend this Ayurvedic herb with a large slew of applications.

"It is specifically known to produce a calming effect, which may be beneficial to sleep. While most studies on ashwagandha have been done on animals, one notable human study demonstrated that ashwagandha may very well improve sleep," says Rose. "In order to sleep well, you have to have a sense of calm. In this particular study, it was shown that ashwagandha did just that and improved sleep quality while decreasing the amount of time it takes to go from being fully awake to sleeping."

Hopping aboard the CBD train may have a positive impact on your sleep. "One sleep-promoting supplement I would recommend is cannabidiol or CBD. CBD, one of the main cannabinoids in the cannabis plant, interacts with the endocannabinoid system which helps regulate many processes in the body," says Ivanir. "While difficulty sleeping may be due to a variety of reasons, if it is caused by factors such as anxiety CBD may be beneficial. Research shows that CBD can have a calming effect, which can help reduce stress and improve sleep quality. Furthermore, if chronic pain is interrupting sleep, CBD has also been shown to help relieve pain and thereby aid in sleep. CBD may also interact with receptors in the brain that govern sleep-wake cycles, promoting sleep directly," she continues.

Visit link:

Best Supplements to Take Before Bed, According to Dietitians - Eat This, Not That

What Happened to Jason Giambi and Where is He Now? – Fanbuzz

Former New York Yankees slugger Jason Giambi is one of baseballs all-time greatest hitters. He played 20 years in MLB and won a multitude of awards throughout his career.

Still, Giambi filled his time in The Show with controversy, including the performance-enhancing drugs scandal that rocked Major League Baseball in the mid-2000s.

Giambi retired from professional baseball at the age of 43, but what is the former first baseman doing now?

RELATED: Mark McGwire Cheated. What Happened to Him After Baseball?

Jason Giambi was born in West Covina, California, and attended South Hills High School. He has a brother, Jeremy Giambi, who also played in MLB.

Jason Giambi played college baseball at California State University at Long Beach before being drafted as a second-round pick by the Oakland Athletics in 1992.

Giambi played his first MLB game in 1995 against the Texas Rangers. After that, he spent the first seven years of his career in the Bay Area and put up some monster numbers for Oakland.

In 2000, Giambi was named the American League MVP after hitting 44 home runs with 137 RBIs. That year, Giambino made his first All-Star Game while leading the league in walks and on-base percentage.

After another dominant campaign in 2001, and a second-consecutive playoff defeat at the hands of the Yankees, Giambi left the small-market team in Oakland. He was a hot commodity as a free agent, having just led the league in slugging percentage.

So the New York Yankees signed Giambi to spend the next seven seasons at first base and as a designated hitter in the Bronx at Yankee Stadium under manager Joe Torre.

Giambi got off to a hot start in pinstripes, stringing together back-to-back 41-home run seasons and eclipsing the 100-RBI threshold.

In 2003, Giambi logged a .250 batting average and launched 41 bombs to help lead the Yankees to the World Series. The team fell short of its goal, unfortunately, in a tough loss to the Florida Marlins.

Giambi left the Yankees in 2008 as a 37-year-old and returned to the Athletics. He was cut midway through the 2009 season and subsequently signed with the Colorado Rockies.

He played for the Rockies from 2009-12 before finishing his career with the Cleveland Indians.

Giambi retired after the 2014 season as a five-time All-Star, one-time AL MVP, and two-time Silver Slugger. He featured in 2,260 regular-season games and 45 postseason games throughout his career.

While Jason Giambis career was filled with terrific seasons and many home runs, there was also quite a bit of controversy surrounding the baseball player.

Giambi was one of the MLB players at the forefront of the BALCO Scandal, which outed players who had proven to be using illegal human growth hormones and other performance-enhancing drugs.

Giambi came clean and admitted to using banned substances at a 2003 grand jury hearing. Among various other transcripts, that testimony was obtained by the San Francisco Chronicle and released to the public.

In 2007, Giambi issued an apology for his involvement and participation in the PED scandal. While he was initially scrutinized heavily for his actions, he found that issuing a heartfelt apology resulted in him earning forgiveness from those across the league.

Giambi, among others like Alex Rodriguez, Barry Bonds, and Mark McGwire, all came under intense scrutiny for their use of HGH throughout their careers, and its played a significant factor in keeping some star players out of the Hall of Fame.

These days, Jason Giambi resides in Henderson, Nevada near Las Vegas with his wife Kristian. The couple has three children together: two daughters and a son named Tristan.

Tristan Giambi has started Little League, and Jason told MLB.coms Alfred Santasiere III how he became the coach of his sons team. While Giambi expressed his interest in returning to baseball in a coaching role, it seems his top priority as of now is his family.

The last weve heard from Giambi was his response to the Houston Astros sign-stealing scandal, to which he stated that the Astros antics were similar to PED use and that teams will always be seeking out ways to gain a competitive advantage.

Read the original:

What Happened to Jason Giambi and Where is He Now? - Fanbuzz

Human Growth Hormone Market by Technology, Solutions, Application, Price, Demand Analysis and Growth Opportunities to 2025 – Express Journal

The latest research on Human Growth Hormone Market 2020-2025. A comprehensive report accumulated to offer latest insights about acute features of the Human Growth Hormone market. The report accommodates different market predictions related to market to size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factor. The report furthermore offers an all-out research of trends to come examples and movements of the market. Additionally, the document comprises of insights regarding the challenges & restraints faced by the key contenders and new entrants alongside its impact on the y-o-y growth rate and future remuneration of this market.

The report evaluates the competitive arena of the Human Growth Hormone market and provides crucial information regarding the raw materials used and downstream buyers. The effect of COVID-19 pandemic on growth opportunities of this industry vertical has also been mentioned in the document.

From the regional point of view of the Human Growth Hormone market:

Request Sample Copy of this Report @ https://www.express-journal.com/request-sample/423396

Highlighting the competitive scenario of Human Growth Hormone market:

Other parameters stated in the Human Growth Hormone market report:

Offerings of the Global Human Growth Hormone market research study:

Key Questions Answered In this Report:

Request Customization on This Report @ https://www.express-journal.com/request-for-customization/423396

Original post:

Human Growth Hormone Market by Technology, Solutions, Application, Price, Demand Analysis and Growth Opportunities to 2025 - Express Journal

Business Overview of Human Growth Hormone Industry Size, Global Market Trends and Forecast to 2021-2026 Jumbo News – Jumbo News

A new research report published by InForGrowth by Human Growth Hormone Market Size 2021-2026 provides a comprehensive segmental study with industry-best intelligence on the current and future market positions of key segments of the global Human Growth Hormone market. It helps players to become aware of upcoming segments and key growth pockets so that they could cash in on some rewarding opportunities available in the global Human Growth Hormone market. Each segment is analyzed with a broad focus on its market share, growth journey during the forecast period, and future growth prospects.

Major Key Players Covered in The Human Growth Hormone Market Report include: Novo Nordisk, Pfizer, Eli Lilly, Merck Serono, F. Hoffmann-La Roche, Ferring Pharmaceuticals, GeneScience Pharmaceuticals, Ipsen, LG Life Sciences, Sandoz International, Anhui Anke Biotechnology

Get a Sample Copy of this Human Growth Hormone Market Report andAvail of Minimum 15% discount @https://www.inforgrowth.com/sample-request/5890514/Human Growth Hormone-market

The report also covers the recent agreements including merger & acquisition, partnership or joint venture, and latest developments of Top Players to sustain in the global competition of the Human Growth Hormone market. The main objective of the Human Growth Hormone market report is to provide insights on the post-COVID-19 impact which will help market players in this field evaluate their business approaches. The analysts have mainly segmented the global Human Growth Hormone market into product type, application, and region.

Based on Type, the market has been segmented into:

Based on application, the market has been segmented into:

This Human Growth Hormone market report comes with a little company outline, earnings dialog, advantage, latest events and product offering, and ways of these gamers. The maturation of the substantial associations alongside their resources such as development, price, and customer satisfaction are gleaned from your analysis document about the International Human Growth Hormone market. From the providers particular needs, we may even provide customization for International Human Growth Hormone Market together with most of the info that is chosen.

For more Customization of Human Growth Hormone, Market Report reach us @https://www.inforgrowth.com/customization/5890514/Human Growth Hormone-market

Geographically, this report is segmented into several key Regions along with their respective countries, with production, consumption, revenue (million USD), and market share and growth rate of Human Growth Hormone in the following regions:

Predominant Questions Answered in This Report Are:

Table of Content:

Chapter 1. Human Growth Hormone Market Research Objective

Chapter 2. Executive Summary

Chapter 3. Strategic Analysis

Chapter 4. Human Growth Hormone Market Dynamics

Chapter 5. Segmentation & Statistics

Chapter 6. Market Use case studies

Chapter 7. KOL Recommendations

Chapter 8. Investment Landscape

Chapter 9. Competitive Intelligence

Chapter 10. Company Profiles

Chapter 11. Appendix

Ask for more discount packages for multiple reports @ https://inforgrowth.com/contact

For More Details Contact Us:

Contact Name:Rohan

Email:[emailprotected]

Phone:1-909-329-2808

Excerpt from:

Business Overview of Human Growth Hormone Industry Size, Global Market Trends and Forecast to 2021-2026 Jumbo News - Jumbo News

Growth Hormone Deficiency Market Insight on the Important Factors and Trends Influencing the Industry 2027 KSU | The Sentinel Newspaper – KSU | The…

The research report presents a comprehensive assessment of the Growth Hormone Deficiency Market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. Growth Hormone Deficiency with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. Growth Hormone Deficiency market future, competitive analysis by Growth Hormone Deficiency Market Players, Deployment Models, Opportunities, Future Roadmap, Value Chain, Major Player Profiles.

Growth Hormone Deficiency market report records and concentrates the main rivals likewise furnishes the bits of knowledge with vital industry Analysis of the key elements impacting the market. Growth Hormone Deficiency Market Report contains revenue numbers, product details, and sales of the major firms. Additionally, it provides a breakdown of the revenue for the global Growth Hormone Deficiency market. The report contains basic, secondary and advanced information pertaining to the Growth Hormone Deficiency Market global status and Growth Hormone Deficiency market size, share, growth, trends analysis, segment and forecast.

Global growth hormone deficiency market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Emerging markets and huge investment in research and development are the factors responsible for the growth of this market.

Get Free PDF Sample Copy of This Report:- https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-growth-hormone-deficiency-market

Market Report Scope:

Countries and Geographies: The geographical regions data will help you in targeting all the best-performing regions. The section covers: (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China)

Download Exclusive Sample (350 Pages PDF) Report: To Know the Impact of COVID-19 on this Industry:https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-growth-hormone-deficiency-market

The Objectives of the Growth Hormone Deficiency Market Report:

Growth Hormone Deficiency Market competition by top manufacturers/players, with sales volume, Price (USD/Unit), Revenue (Million USD) and market share for each manufacturer/player; the top players including:

OPKO Health, Inc, Allergan, Novo Nordisk A/S, Sanofi, Abbott, TherapeuticsMD, Inc., Mithra Pharmaceuticals, Pfizer Inc., Novartis AG, Bayer AG, Mylan N.V., Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Merck KGaA and others. .

Complete Report is Available (Including Full TOC, List of Tables & Figures, Graphs, and Chart):https://www.databridgemarketresearch.com/toc/?dbmr=global-growth-hormone-deficiency-market

Major Points Covered in Growth Hormone Deficiency Market Report:-

Have Any Query? Ask Our Expert at: https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-growth-hormone-deficiency-market

Customization of the Report:

Data Bridge Market Research also provides customization options to tailor the reports as per client requirements. This report can be personalized to cater to your research needs. Feel free to get in touch with our sales team, who will ensure that you get a report as per your needs.

Link:

Growth Hormone Deficiency Market Insight on the Important Factors and Trends Influencing the Industry 2027 KSU | The Sentinel Newspaper - KSU | The...

Global Human Growth Hormone Market is expected to grow at a CAGR of 8.9% over the Forecast Period The Manomet Current – The Manomet Current

The growing awareness regarding the efficacies of human growth hormone therapies to treat a variety of disorders is creating high demand in the human growth hormone market. These medications are being used for the treatment of growth failure disorders (noonan syndrome, turner syndrome and idiopathic short stature), growth hormone deficiency, intestinal disorder (short bowel syndrome) and HIV-related weight loss or wasting. Public health regulatory agencies around the world have recognized the capabilities of growth hormone drugs and are granting approvals for use in various cases. For instance, in July 2018, the U.S. Food and Drug Administration (FDA) agency approved ZOMACTON, a growth hormone drug of Ferring Pharmaceuticals, for five additional pediatric indications such as idiopathic short stature, short stature associated with turner syndrome, growth failure in short stature homeobox-containing gene (SHOX) deficiency and short stature born small for gestational age (SGA). The agency also approved this drug for replacement of endogenous growth hormones in adults. Government agencies have also initiated campaigns to create awareness regarding early detection of growth disorders in children and to adopt growth hormone treatment. Thus, the growing awareness regarding multiple applications of growth hormone therapies is driving the demand in global human growth hormone market.

Request for Sample Copy of This Report@ https://www.absolutemarketsinsights.com/request_sample.php?id=701

Amidst the recent outbreak of COVID-19 pandemic, medical professionals and scientists are conducting research to develop growth hormone therapy for treatment of active COVID-19 patients and speed-up their recovery. These on-going research and development activities are anticipated to fuel the growth of global human growth hormone market.

In terms of revenue, global human growth hormone market was valued at US$ 4109.23 million in 2019 and is expected to reach US$ 5819.32 million by 2028, growing at an estimated growth rate of 8.9% over the forecast period. The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.

The detailed research study provides qualitative and quantitative analysis of human growth hormone market. The market has been analyzed from demand as well as supply side. The demand side analysis covers market revenue across regions and further across all the major countries. The supply side analysis covers the major market players and their regional and global presence and strategies. The geographical analysis done emphasizes on each of the major countries across North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

Enquiry Before Buying @ https://www.absolutemarketsinsights.com/enquiry_before_buying.php?id=701

Key Findings of the Report:

Request for Customization@ https://www.absolutemarketsinsights.com/request_for_customization.php?id=701

Global Human Growth Hormone Market:

Get Full Information of this premium report@ https://www.absolutemarketsinsights.com/reports/Global-Human-Growth-Hormone-Market-2019-2027-701

About Us:

Absolute Markets Insights strives to be your main man in your business resolve by giving you insight into your products, market, marketing, competitors, and customers. Visit

Contact Us:

Email id: sales@absolutemarketsinsights.com

Contact Name: Shreyas Tanna

Phone: +91-740-024-2424

See more here:

Global Human Growth Hormone Market is expected to grow at a CAGR of 8.9% over the Forecast Period The Manomet Current - The Manomet Current

Hormone Infusion Pumps Market Projected to Show Strong Growth by end of 2027 | Becton, Dickinson and Company (BD), B. Braun Melsungen, Baxter…

A hormone infusion pumps infuses fluids such as medication or nutrients into a patients central blood circulatory system when manual fluid administration would be expensive, unreliable or impractical.

Most hormone infusion pumps use the intravenous route of drug administration although subcutaneous, arterial and epidural infusions are also commercially available.

The rising incidences of chronic diseases such as Cancer, Diabetes, autoimmune diseases are fuelling a large demand for the hormone infusion pumps market.

According to Survey, almost 40 % of cancer patients suffer from chronic pain needing chronic drugs administration which is resulting in wide adoption of hormone infusion pumps. The growing ambulatory surgical services coupled with growing use of potent drugs with narrow safety window is another driver of the market.

Request a sample copy of this report @ Click here:

https://www.reportconsultant.com/request_sample.php?id=83996

Key Players

Some of the Market Players include are Becton, Dickinson and Company (BD), B. Braun Melsungen, Baxter International, Fresenius Kabi, ICU Medical, Medtronic, Moog Inc., Smiths Medical, Terumo Corporation, Roche Diagnostics, and Halyard Health.

The report offers key drivers that propel the growth in the global Hormone Infusion Pumps market. These insights help market players in devising strategies to gain market presence. The research also outlined restraints of the market. Insights on opportunities are mentioned to assist market players in taking further steps by determining potential in untapped regions.

Leading market players analyzed in the report include Celanese Corporation. These players have adopted various strategies including expansions, mergers & acquisitions, joint ventures, new product launches, and collaborations to gain a strong position in the industry.

Detailed analysis on operating business segments, product portfolio, business performance, and key strategic developments is offered in the research.

Hormone Infusion Pumps Market Segmentation

Based on delivery

Based on applications

Based on end users

Inquire Before Buying This Research Report:

https://www.reportconsultant.com/enquiry_before_buying.php?id=83996

Regional Analysis:

Key Benefits:

Detailed TOC of Global Hormone Infusion Pumps Market Research Report-

Hormone Infusion Pumps Market Introduction and Market Overview

Hormone Infusion Pumps Market, by Application

Hormone Infusion Pumps Market Industry Chain Analysis

Hormone Infusion Pumps Market, by Type

Industry Manufacture, Consumption, Export, Import by Regions

Industry Value ($) by Region

Global Hormone Infusion Pumps Market Status and SWOT Analysis by Regions

Major Region of Hormone Infusion Pumps Market

Major Companies List

Conclusion

About us:

Report Consultant is a prime destination for your business aptitude and analytical solutions because we provide qualitative and quantitative sources of information that are proficient to give one-stop solutions. We skillfully syndicate qualitative and quantitative research in exact proportions to have the best report, which not only gives the most recent insights but also assists you to grow.

Contact us:

Rianna Singh

(Report Consultant)

Contact No: +81-368444299

sales@reportconsultant.com

http://www.reportconsultant.com

See the original post here:

Hormone Infusion Pumps Market Projected to Show Strong Growth by end of 2027 | Becton, Dickinson and Company (BD), B. Braun Melsungen, Baxter...

Follow-On-Biologics Market 2021 | Trends, Growth Demand, Opportunities & Forecast To 2027 The Manomet Current – The Manomet Current

In-depth analysis ofGlobal Follow-On-Biologics Marketshare, growth prospects, value & volume, and market prediction is given in the research report. The Follow-On-Biologics industry is valued at xx million and will expand xx million during the projected period with the registration CAGR of xx percent. The major aim of the report is to identify, segment, and estimate the size of the Follow-On-Biologics market on the basis of the sector, end-user, type of product, and key geographical regions. The study also includes the current status of the industry, market share, competitive environment, present and future developments, threats & opportunities, market factors, distributors, and channels of distribution.

Key Manufacturers Analysis:Hospira, Biocon, Celltrion, Merck Serono, Novartis, Teva Pharmaceutical Industries Ltd., Synthon Pharmaceuticals Inc, Biogen idec Inc, LG Life Sciences

Request a sample of Follow-On-Biologics Market report @https://www.marketresearchstore.com/sample/follow-on-biologics-market-798295

Additionally, in terms of value and volume, the Follow-On-Biologics market study provides a reliable calculation of the industry share. Top-down and bottom-up methods are both used to predict and calculate the global market share of the industry. The Follow-On-Biologics market study anticipates the scale of the worlds number of multiple contingent sub-markets. With the assistance of primary as well as secondary analysis, major players in the Follow-On-Biologics market have been analyzed.

Segmentation by Type:Human growth hormone, Erythropoietin, Monoclonal antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor, Peptide

Segmentation by Application:Blood disorders, Oncology diseases, Chronic and autoimmune diseases, Growth hormone deficiencies

Region Segmentation:

North America Country (United States, Canada)South AmericaAsia Country (China, Japan, India, Korea)Europe Country (Germany, UK, France, Italy)Other Country (Middle East, Africa, GCC)

Browse the complete report @https://www.marketresearchstore.com/market-insights/follow-on-biologics-market-798295

Precise market shares of the correct research methodologies are also included in this research article. Similarly, with the assistance of secondary analysis, the Follow-On-Biologics market study prepared with all percentage shares, breakdowns, and splits has been reviewed and checked by primary sources. Moreover, by using SWOT analysis such as Power, Vulnerability, Opportunities, and Risks, the study offers an in-depth analysis of the Follow-On-Biologics industry.

In addition, the Follow-On-Biologics market study also provides a detailed survey of the worlds main manufacturers, which relies on the industrys different priorities, such as business profiles, supply quantity, product description, critical raw materials, and the industrys financial structure. Similarly, on the basis of a detailed backdrop analysis, the article is analyzed and studied. The Follow-On-Biologics market report, therefore, focuses on the data related to the different market segmentation, regional segmentation, market trends, market growth drivers, and a complete analysis of this markets competitive overview.

Furthermore, a comprehensive analysis of business profiles, which introduce multiple tactics to gain their position in the global market, is covered by this research article. However, their market share, product intake, new product releases, and deep knowledge about the tactics they adopt provide the business profiles of the top vendors. With the help of many analysis methodologies, the Follow-On-Biologics market study delivers detailed and thorough insights into global business trends and dynamics. This study also covers the latest information on business risks and the function of the supply chain in the industry. Similarly, the Follow-On-Biologics market research study presents a variety of common threats and opportunities. This research provides industry figures of the past, present, and future that will help analyze critical factors of the global Follow-On-Biologics market.

Major Points from Table of Content:

Section 1 Follow-On-Biologics Product DefinitionSection 2 Global Follow-On-Biologics Market Manufacturer Share and Market OverviewSection 3 Manufacturer Follow-On-Biologics Business IntroductionSection 4 Global Follow-On-Biologics Market Segmentation (Region Level)Section 5 Global Follow-On-Biologics Market Segmentation (Product Type Level)Section 6 Global Follow-On-Biologics Market Segmentation (Industry Level)Section 7 Global Follow-On-Biologics Market Segmentation (Channel Level)Section 8 Follow-On-Biologics Market Forecast 2019-2024Section 9 Follow-On-Biologics Segmentation Product TypeSection 10 Follow-On-Biologics Segmentation IndustrySection 11 Follow-On-Biologics Cost of Production Analysis

Make an inquiry of this report @https://www.marketresearchstore.com/inquiry/follow-on-biologics-market-798295

About Us:

MarketResearchStore.comis a single destination for all the industry, company, and country reports. We feature a large repository of the latest industry reports, leading and niche company profiles, and market statistics released by reputed private publishers and public organizations.

Contact the US:

Joel JohnSuite #8138, 3422 SW 15 Street,Deerfield Beach, Florida 33442United StatesToll Free: +1-855-465-4651 (USA-CANADA)Tel: +1-386-310-3803Web:http://www.marketresearchstore.comEmail:sales@marketresearchstore.com

Read the rest here:

Follow-On-Biologics Market 2021 | Trends, Growth Demand, Opportunities & Forecast To 2027 The Manomet Current - The Manomet Current

Agency 100 2021: Sound Healthcare Communications – Agency 100 – MM+M – Medical Marketing and Media – Medical Marketing and Media

When Sound Healthcare Communications managing partner, executive creative director Jeff Hack is asked about the genesis of his companys name, he says that it represents more than mere lip service.

Our name is no mistake. In fact, its our guiding principle, he explains.

Indeed, Hack says that the notion of soundness has been the seven-year-old agencys North Star since its inception. Sound is a word that has deep meaning to us sound foundation, sound results, sound strategy, sound ideas, sound thinking, he continues. We wanted to build an agency that is sound across the board, from client services to strategy to creative, and I think weve done that.

Hack believes that clients respond to the lack of flashiness, pointing to organic growth the agency enjoyed at the height of the pandemic as evidence. Sound expanded its relationship with Pfizer in the rare disease space to include an AOR assignment on Somatrogon, which treats pediatric growth hormone deficiency.

The agency ended the year with nine new assignments in hand, including work from Boehringer Ingelheim (on the companys KRAS cancer franchise), Incyte (blood cancer drug parsaclisib), Apellis Pharmaceuticals (on a treatment for geographic atrophy), CareMetx (corporate), Sobi (corporate and rheumatoid arthritis/neonatal onset multisystem inflammatory disease drug Kineret) and Merck (vaccines and heart failure drug Verquvo).

On the back of that new business, revenue ticked up slightly, from $12.2 million in 2019 to $12.4 million in 2020. The firm grew its number of clients from 11 to 14; its growth was split 50/50 between new clients and existing ones.

Sound ended the year with 68 full-timers on hand, up from 65 at the end of 2019. Additions included three former Havas staffers: SVP, creative director Kristen Pilkiewicz; VP, account group supervisor Allie Haran; and VP, associate creative director, copy Emily Leonard.

Pilkiewiczs role is a new one for Sound and a pivotal one. As soon as she arrived, Hack notes, Pilkiewicz set about adjusting the agencys focus in a range of different areas.

Kristens got the big agency experience and shes got the launch experience. But she also perfectly fits the mold of a Sounder, Hack says. Shes a creative leader whos constantly inspiring the creative department with the latest design trends or typography or 3-D technologies. Shes constantly trying to make us better and smarter.

Other changes during 2020 include the formation of a social media team and the debut of an in-house presentation series. The latter is designed to get us thinking about new ways to help our clients, Hack explains, pointing to a recent talk led by the leader of a sonic branding agency. Some brands have sounds Intel has a sound and P.C. Richard has a sound. Its not an area that a lot of people know about in our space, so it was wonderfully interesting.

Sound also took some time during 2020 to reassess its place in the larger agency world and the types of clients with which it wants to work.

We took advantage of quarantine to refine our story and ask ourselves, Why are we relevant? And why is that important to our customers? Hack says. Its all about finding the right fit for Sound and for our culture. For the value that we bring, it has to be a good match.

. . .

Area 23s 10% of a Campaign ad for Daiichi Sankyos iron-deficiency drug Injectafer. The beauty lies in its simplicity. To only utilize a tiny portion of the usable space on the page highlights the problem so quickly and elegantly. I also have to applaud the bravery of the client to embrace this unexpected approach. Jeff Hack

From the June 01, 2021 Issue of MM+M - Medical Marketing and Media

See the article here:

Agency 100 2021: Sound Healthcare Communications - Agency 100 - MM+M - Medical Marketing and Media - Medical Marketing and Media